Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice

Inflammation Research

Volumn 50, Issue 9, 2001, Pages 435-441

  Igaz, P ^a   Toth S ^a   Falus, A ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cytokine; JAK STAT; Knockout; SOCS

Indexed keywords

CYTOKINE; INTERFERON; JANUS KINASE; STAT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; INTERFERON PRODUCTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034832208     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000267     Document Type: Review

References (85)

1. Cytokine signal transduction
2. The JAK-STAT pathway: Specific signal transduction from the cell membrane to the nucleus
3. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
4. Interleukin-6 type cytokine signalling through the gp130/JAK/STAT pathway
5. STATs and gene regulation
6. The Janus kinase family of protein tyrosine kinases and their role in signaling
7. Transcription factor activity of STAT proteins: Structural requirements and regulation by phosphorylation and interacting proteins
8. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation
9. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
10. A family of cytokine-inducible inhibitors of signalling
11. A new protein containing an SH2 domain that inhibits JAK kinases
12. Structure and function of a new STAT-induced STAT inhibitor
13. Twenty proteins containing a C-terminal SOCS box form five structural classes
14. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of STAT5 in proliferation
15. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
16. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
17. SOCS: Physiological suppressors of cytokine signaling
18. The conserved SOCS box motif in suppressors of cytokine-signalling binds to elongins B and C and may couple bound proteins to proteosomal degradation
19. Negative regulation of the JAK/STAT pathway
20. Dual signaling role of the protein tyrosine phophatase SHP-2 in regulating expression of acute-phase plasma protein by interleukin-6 cytokine receptors in hepatic cells
21. Inhibition of STAT1-mediated gene activation by PIAS1
22. Negative regulators of cytokine signal transduction
23. Disruption of the JAK1 gene demonstrates obligatory and non redundant roles of the JAKs in cytokine-induced biologic responses
24. JAK2 is essential for signaling through a variety of cytokine receptors
25. JAK2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis
26. Defective lymphoid development in mice lacking Jak3
27. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
28. The role of JAK3 in lymphoid development. Activation and signalling
29. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
30. Lymphoid development in mice with a targeted deletion of the interleukin-2 receptor γ chain
31. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
32. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease
33. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
34. Immune response in Stat2 knockout mice
35. Physiological significance of STAT proteins: Investigation through gene disruption in vivo
36. Targeted disruption of the mouse STAT3 gene leads to early embryonic lethality
37. The role of STATs in proliferation, differentiation and apoptosis
38. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain
39. Impaired IL-12 responses and enhanced development of Th2 cells in STAT4 deficient mice
40. Requirement for STAT4 in interleukin 12 mediated responses of natural killer and T cells
41. Signal transducer and activator of transcription factor 6 (STAT6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus protection
42. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice
43. STAT5a is mandatory for adult mammary gland development and lactogenesis
44. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response
45. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
46. An indirect effect of STAT5a in IL-2 induced proliferation: A critical role for STAT5a in IL-2-mediated IL-2 receptor alpha chain induction
47. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity
48. Stat5a and Stat5b proteins have essential and nonessential, or redundant roles in cytokine responses
49. STAT5 is required for IL-2-induced cell cycle progression of peripheral T cells
50. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
51. Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1
52. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
53. Accelerated apoptosis of lymphocytes by augmented induction Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice
54. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
55. Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kiss1 suckling mice
56. The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-γ and lacking the SOCS1 gene
57. Suppressors of cytokine signalling (SOCS): Negative regulators of signal transduction
58. Gigantism in mice lacking suppressor of cytokine signalling-2
59. SOCS3 is essential in the regulation of fetal liver erythropoiesis
60. Mutation at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
61. Genetic evidence that SHP-2 tyrosine phosphatase is a signal enhancer of epidermal growth factor receptor in mammals
62. The role of phosphotyrosine phosphatases in haemopoietic cell signal transduction
63. A Tel-JAK2 fusion protein with constitutive kinase activity in human leukemia
64. Proliferation of adult T cell leukemia/lymphoma cells is associated with constitutive activation of JAK/STAT protein
65. Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells
66. Inhibition of constitutively activated STAT3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells
67. Constitutive activation of JAKs and STATs in Bcr-Abl expressing cell lines and peripheral blood cells derived from leukemic patients
68. Activation of JAK/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome
69. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukemia
70. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemia cell lines
71. Potential role of Bcr-Abl in the activation of JAK1 kinase
72. B-lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT)1 and STAT3 constitutively phosphorylated on serine residues
73. STAT3 as an oncogene
74. Expression of the JAK and STAT superfamilies in human meningiomas
75. Multiple γc-dependent cytokines regulate T-cell development
76. Mutations of the Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
77. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
78. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans
79. + severe combined immunodeficiency
80. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes
81. Cardiotrophin-1: A multifunctional cytokine that signals via LIF receptor-gp130 dependent pathways
82. Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes
83. Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart
84. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes
85. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma